Country for PR: China
Contributor: PR Newswire Asia (China)
Tuesday, May 26 2020 - 08:00
IVI Standardizes on Veeva Vault QualityDocs to Improve Operational Efficiency
SEOUL, South Korea, May 26, 2020 /PRNewswire-AsiaNet/ --

Veeva Vault QualityDocs gives IVI better control and real time visibility into 
documents and processes for audits 

Veeva Systems (NYSE: VEEV) today announced that the International Vaccine 
Institute (IVI), a not-for-profit International Organization established in 
1997 as an initiative by the United Nations Development Programme (UNDP), has 
implemented Veeva Vault QualityDocs to improve control and real time visibility 
of standard operating procedures (SOPs) for audits and inspections. The move 
from paper-based processes to Vault QualityDocs will better enable IVI to meet 
compliance and GxP requirements of major drug administrations.

Vault QualityDocs, a modern, cloud application for GxP document control and 
management, will enable IVI to deliver greater compliance, improved quality, 
and reduced operational overhead. IVI can accelerate the review and approval 
workflows of SOPs and easily share GxP documents among employees and partners. 
Vault QualityDocs is part of Veeva Vault Quality Suite which unifies quality 
processes, document control, and training, to drive global operational 

"Veeva allows our organisation to improve compliance and ensure all SOP and 
company documents are stored in one validated system that is compliant with the 
FDA's 21 CFR part 11 regulation," said Tobin Guarnacci, head of quality 
management GxP at IVI. "We now have a single source of truth that helps us and 
our partners be audit-ready."

"Veeva will enable IVI to increase operational efficiencies and improve quality 
processes with an easy to use and manage cloud solution," said Chris Shim, Vice 
President, Vault R&D APAC & China. "We are honoured to partner with them and 
help achieve their mission to develop safe, effective, and affordable vaccines 
for global public health."

Learn more about how Veeva Vault QualityDocs is helping life sciences 
organisations provide superior ease-of-use and seamless collaboration at

About the International Vaccine Institute 

The International Vaccine Institute (IVI) is a nonprofit inter-governmental 
organization established in 1997 as an initiative of the United Nations 
Development Programme (UNDP). Headquartered in Seoul, South Korea, IVI was the 
first international organization hosted by Korea. IVI has 35 signatory 
countries and the World Health Organization (WHO) on its treaty, including 
Korea, Sweden and India as state funders.

Our mandate is to make vaccines available and accessible for the world's most 
vulnerable people, focusing on infectious diseases of global health importance 
such as cholera, typhoid, shigella, salmonella, schistosomiasis, Group A Strep, 
Hepatitis A, HPV, TB, HIV, MERS-CoV, as well as antimicrobial resistance. 

About Veeva Systems

Veeva Systems Inc. is the leader in cloud-based software for the global life 
sciences industry. Committed to innovation, product excellence, and customer 
success, Veeva serves more than 850 customers, ranging from the world's largest 
pharmaceutical companies to emerging biotechs. Veeva is headquartered in the 
San Francisco Bay Area, with offices throughout North America, Europe, Asia, 
and Latin America. Please visit

Forward-looking Statements

This release contains forward-looking statements, including the market demand 
for and acceptance of Veeva's products and services, the results from use of 
Veeva's products and services, and general business conditions, particularly in 
the life sciences industry. Any forward-looking statements contained in this 
press release are based upon Veeva's historical performance and its current 
plans, estimates, and expectations, and are not a representation that such 
plans, estimates, or expectations will be achieved. These forward-looking 
statements represent Veeva's expectations as of the date of this press 
announcement. Subsequent events may cause these expectations to change, and 
Veeva disclaims any obligation to update the forward-looking statements in the 
future. These forward-looking statements are subject to known and unknown risks 
and uncertainties that may cause actual results to differ materially. 
Additional risks and uncertainties that could affect Veeva's financial results 
are included under the captions, "Risk Factors" and "Management's Discussion 
and Analysis of Financial Condition and Results of Operations," in the 
company's filing on Form 10-K for the period ended January 31, 2020. This is 
available on the company's website at under the Investors section and 
on the SEC's website at Further information on potential risks that 
could affect actual results will be included in other filings Veeva makes with 
the SEC from time to time.

Jacqueline Davis
Veeva Systems
SOURCE  Veeva Systems

Image Attachments Links:


   Caption: Veeva Logo

Veeva Logo.jpg